Biotech Values

[DewDiligence]

There have been some posts about 10b5 plans and insider sales and lack of and what they mean. I am one who while I don't like to see insiders sell try not to over-read it.

That is (IMO) the view of most regular posters on this board with the notable exception of jbog, who apparently thinks 10b5-1 sales should be treated no differently than voluntarily-timed sales.

Where 10b5-1 sales become interesting for gauging the sentiment of insiders is if there’s a change in the number of insiders who have plans or a change in the activity level of existing plans.